![Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine](https://www.frontiersin.org/files/Articles/660986/fcvm-08-660986-HTML/image_m/fcvm-08-660986-g001.jpg)
Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update | Cardiovascular Medicine
![Management of atrial fibrillation breakthrough with rapid ventricular... | Download Scientific Diagram Management of atrial fibrillation breakthrough with rapid ventricular... | Download Scientific Diagram](https://www.researchgate.net/publication/289555155/figure/fig1/AS:411360715395077@1475087445879/Management-of-atrial-fibrillation-breakthrough-with-rapid-ventricular-response-AAD.png)
Management of atrial fibrillation breakthrough with rapid ventricular... | Download Scientific Diagram
![Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines - International Journal of Cardiology Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bb4828d2-7f4b-4ece-9021-da244efd4939/gr1_lrg.jpg)
Oral anticoagulant therapy in adults with congenital heart disease and atrial arrhythmias: Implementation of guidelines - International Journal of Cardiology
![References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8a0aa113-6f1f-442e-b028-2c62a6f40125/gr1.jpg)
References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm
![Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000990157/2003648134/gr1.gif)
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial - The Lancet
![Warfarin versus aspirin for the prevention of atrial fibrillation related stroke - BPJ 19 February 2009 Warfarin versus aspirin for the prevention of atrial fibrillation related stroke - BPJ 19 February 2009](https://bpac.org.nz/bpj/2009/february/img/warfarin_fig1.gif)
Warfarin versus aspirin for the prevention of atrial fibrillation related stroke - BPJ 19 February 2009
![Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/11064ab7-590c-4e3c-bf44-87df147d66be/gr1_lrg.jpg)
Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial - The Lancet Neurology
![References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7885a13c-e9f2-4c9c-b6f1-d66427faa7d4/gr1_lrg.jpg)
References in Thromboembolic, bleeding, and mortality risks among patients with nonvalvular atrial fibrillation treated with dual antiplatelet therapy versus oral anticoagulants: A population-based study - Heart Rhythm
![Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke | Journal of Comparative Effectiveness Research Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke | Journal of Comparative Effectiveness Research](https://www.futuremedicine.com/na101/home/literatum/publisher/fum/journals/content/cer/2021/cer.2021.10.issue-2/cer-2020-0224/20210205/images/medium/cer-2020-0224ga.eps.gif)
Cost–effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke | Journal of Comparative Effectiveness Research
![Doctors advised against aspirin for patients with irregular heart rhythm | National Institute for Health and Care Excellence | The Guardian Doctors advised against aspirin for patients with irregular heart rhythm | National Institute for Health and Care Excellence | The Guardian](https://i.guim.co.uk/img/static/sys-images/Guardian/Content_Distribution/General_images/2014/6/17/1403021154673/Aspirin-tablets-in-jar-009.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctYWdlLTIwMTQucG5n&enable=upscale&s=848f20971a231ed5d16627733e3be1f7)
Doctors advised against aspirin for patients with irregular heart rhythm | National Institute for Health and Care Excellence | The Guardian
![Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice | Postgraduate Medical Journal Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice | Postgraduate Medical Journal](https://pmj.bmj.com/content/postgradmedj/89/1052/346/F3.large.jpg)
Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice | Postgraduate Medical Journal
![Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin | Stroke](https://www.ahajournals.org/cms/asset/ae1d4f62-1d89-45e6-a77e-177b70848cd3/3291fig03.jpeg)